Skip to content
Screener

Alkermes ALKS Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$646K+91.7%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$9M-18.2%
LBR
LB Pharmaceuticals IncLBRX
$730K
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$1.27M+10.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$57.3M+25.7%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.25B+87.1%
Enterprise value$9.31B+135%
P/E124.8×+112×
P/S+2.0×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
CURRENT LIABILITIES:
Accounts payable and accrued expenses$332,469$289,565
Accrued sales discounts, allowances and reserves295,645247,126
Operating lease liabilities—short-term7,4776,746
Current portion of long-term debt26,500
Total current liabilities662,091543,437
OPERATING LEASE LIABILITIES—LONG-TERM61,97663,253
CONTINGENT CONSIDERATION136,304

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's operating lease liabilities (current)?
Alkermes (ALKS) reported operating lease liabilities (current) of $7.48M in Q2 2026.
How has Alkermes's operating lease liabilities (current) changed year-over-year?
Alkermes's operating lease liabilities (current) increased by 15.7% year-over-year, from $6.46M to $7.48M.
What is the long-term trend for Alkermes's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Alkermes's operating lease liabilities (current) has grown at a -15.6% compound annual growth rate (CAGR), from $15.73M to $6.75M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Alkermes's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude